Rossari Biotech Ltd Stock Price Today (NSE: ROSSARI)
Fundamental Score
Rossari Biotech Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Rossari Biotech Ltd share price today is ₹513.30, up +0.00% on NSE/BSE as of 20 February 2026. Rossari Biotech Ltd (ROSSARI) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of ₹3.32K (Cr). The 52-week high for ROSSARI share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 24.31x, ROSSARI is currently trading below its industry average P/E of 29.20x. The company has a Return on Equity (ROE) of 12.22% and a debt-to-equity ratio of 0.28.
Rossari Biotech Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Rossari Biotech Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Rossari Biotech Share Price Analysis: A Growth Strategist's Perspective
In the dynamic specialty chemicals sector, characterized by bespoke solutions and evolving regulatory landscapes, consistent innovation is paramount. This analysis examines the financial standing of Rossari Biotech Ltd., focusing specifically on the Rossari Biotech share price and its underlying drivers. Currently trading at ₹519.75, with a Price-to-Earnings (PE) ratio of 24.31, the company presents a compelling case for a deeper dive. This evaluation is part of an 80-parameter fundamental audit verified by Sweta Mishra.
The PE ratio of 24.31 suggests that investors are willing to pay a premium for each rupee of Rossari Biotech's earnings, indicating positive market sentiment regarding its future growth prospects. When compared to sector peers like
Amal, the PE ratio invites questions about relative management quality and the ability to navigate market volatility. Is the premium justified by demonstrably superior operational efficiency, strategic foresight, or stronger customer relationships compared to its competition?A crucial factor in evaluating Rossari Biotech's long-term sustainability is its Return on Capital Employed (ROCE) of 15.8%. This metric illustrates the company's efficiency in generating profits from its invested capital. A higher ROCE indicates that the company is more effective at utilizing its resources, leading to enhanced profitability and potentially a widening economic moat. In Rossari Biotech's case, the 15.8% ROCE suggests a solid foundation for competitive advantage, though continuous improvement is necessary to maintain its edge against rivals like Bhatia Colour and Deep Polymers.
The ability to sustain and improve its ROCE is intimately tied to the company's innovation pipeline and its ability to adapt to changing market demands. The higher the ROCE, the greater the reinvestment capacity for future growth initiatives. Investors should scrutinize Rossari Biotech's capital allocation strategies, R&D spending, and strategic partnerships to assess its potential to further solidify its position in the specialty chemicals market. Continued monitoring of these factors will provide further insights into the long-term drivers of the Rossari Biotech share price.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Rossari Biotech Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ROSSARI across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Excellent ROCE Performance (15.80%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Revenue Growth (17.61%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (28.23% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (15.88% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.28)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (9.35x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (68.17%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
0 factors identified
No significant concerns identified in current analysis.
Rossari Biotech Ltd Financial Statements
Comprehensive financial data for Rossari Biotech Ltd including income statement, balance sheet and cash flow
About ROSSARI (Rossari Biotech Ltd)
Rossari Biotech Ltd (ROSSARI) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Specialty Chemicals sector with a current market capitalisation of ₹3.32K (Cr). Rossari Biotech Ltd has delivered a Return on Equity (ROE) of 12.22% and a ROCE of 15.80%. The debt-to-equity ratio stands at 0.28, reflecting the company's capital structure. Investors tracking ROSSARI share price can monitor key metrics including P/E ratio, promoter holding of 68.17%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
ROSSARI Share Price: Frequently Asked Questions
What is the current share price of Rossari Biotech Ltd (ROSSARI)?
As of 20 Feb 2026, 06:21 am IST, Rossari Biotech Ltd share price is ₹513.30. The ROSSARI stock has a market capitalisation of ₹3.32K (Cr) on NSE/BSE.
Is ROSSARI share price Overvalued or Undervalued?
ROSSARI share price is currently trading at a P/E ratio of 24.31x, compared to the industry average of 29.20x. Based on this relative valuation, the Rossari Biotech Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of ROSSARI share price?
The 52-week high of ROSSARI share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Rossari Biotech Ltd share price?
Key factors influencing ROSSARI share price include quarterly earnings growth (Sales Growth: 17.61%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Rossari Biotech Ltd a good stock for long-term investment?
Rossari Biotech Ltd shows a 5-year Profit Growth of 15.88% and an ROE of 12.22%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.28 before investing in ROSSARI shares.
How does Rossari Biotech Ltd compare with its industry peers?
Rossari Biotech Ltd competes with major peers in the Specialty Chemicals. Investors should compare ROSSARI share price P/E of 24.31x and ROE of 12.22% against the industry averages to determine competitive standing.
What is the P/E ratio of ROSSARI and what does it mean?
ROSSARI share price has a P/E ratio of 24.31x compared to the industry average of 29.20x. Investors pay ₹24 for every ₹1 of annual earnings.
How is ROSSARI performing according to Bull Run's analysis?
ROSSARI has a Bull Run fundamental score of 53.6/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ROSSARI belong to?
ROSSARI operates in the Specialty Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Rossari Biotech Ltd share price.
What is Return on Equity (ROE) and why is it important for ROSSARI?
ROSSARI has an ROE of 12.22%, which shows decent profitability but room for improvement. ROE measures how efficiently Rossari Biotech Ltd generates profits from shareholders capital.
How is ROSSARI debt-to-equity ratio and what does it indicate?
ROSSARI has a debt-to-equity ratio of 0.28, which indicates conservative financing with low financial risk.
What is ROSSARI dividend yield and is it a good dividend stock?
ROSSARI offers a dividend yield of 0.08%, meaning you receive ₹0.08 annual dividend for every ₹100 invested in Rossari Biotech Ltd shares.
How has ROSSARI share price grown over the past 5 years?
ROSSARI has achieved 5-year growth rates of: Sales Growth 28.23%, Profit Growth 15.88%, and EPS Growth 13.88%.
What is the promoter holding in ROSSARI and why does it matter?
Promoters hold 68.17% of ROSSARI shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Rossari Biotech Ltd.
What is ROSSARI market capitalisation category?
ROSSARI has a market capitalisation of ₹3321 crores, placing it in the Small-cap category.
How volatile is ROSSARI stock?
ROSSARI has a beta of N/A. A beta > 1 suggests the Rossari Biotech Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ROSSARI operating profit margin trend?
ROSSARI has a 5-year average Operating Profit Margin (OPM) of 13.47%, indicating the company's operational efficiency.
How is ROSSARI quarterly performance?
Recent quarterly performance shows Rossari Biotech Ltd YoY Sales Growth of 17.61% and YoY Profit Growth of 4.39%.
What is the institutional holding pattern in ROSSARI?
ROSSARI has FII holding of 2.70% and DII holding of 18.18%. Significant institutional holding often suggests professional confidence in the Rossari Biotech Ltd stock.